Search

everythinglearnresearchcommunity

for

Search:↓

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

The Broad Ligament Maneuver effectively relieved PCOS symptoms and restored ovarian function.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Women with acne after adolescence are more likely to have PCOS and should be checked for it.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Hormonal therapies are safe and effective for treating adult women's acne.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.